Complement Dependent and Independent Interaction Between Bovine Conglutinin and Mycobacterium bovis BCG: Implications in Bovine Tuberculosis

Frontiers in Immunology
Arshad MehmoodAnthony G Tsolaki

Abstract

Bovine conglutinin, the first animal collectin to be discovered, is structurally very similar to Surfactant Protein D (SP-D). SP-D is known to interact with Mycobacterium tuberculosis, and the closely-related M. bovis, the causative agent of bovine tuberculosis. We speculated that due to the overall similarities between conglutinin and SP-D, conglutinin is likely to have a protective influence in bovine tuberculosis. We set out to investigate the role of conglutinin in host-pathogen interaction during mycobacterial infection. We show here that a recombinant truncated form of conglutinin (rfBC), composed of the neck and C-type lectin domains, binds specifically and in a dose-dependent manner to the model organism Mycobacterium bovis BCG. rfBC showed a significant direct bacteriostatic effect on the growth of M. bovis BCG in culture. In addition, rfBC inhibited the uptake of M. bovis BCG by THP-1 macrophages (human monocyte lineage cell line) and suppressed the subsequent pro-inflammatory response. Conglutinin is well-known as a binder of the complement activation product, iC3b. rfBC was also able to inhibit the uptake of complement-coated M. bovis BCG by THP-1 macrophages, whilst modulating the pro-inflammatory response. It is l...Continue Reading

References

Jul 1, 1977·Australian Veterinary Journal·A W LepperC W Pearson
Jul 1, 1991·Clinical Microbiology Reviews·J E Figueroa, P Densen
Apr 1, 1990·Scandinavian Journal of Immunology·P Friis-ChristiansenJ C Jensenius
Aug 1, 1995·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·L M O'Reilly, C J Daborn
Oct 15, 1994·The Biochemical Journal·J F Van IwaardenJ A van Strijp
Dec 1, 1993·Mammalian Genome : Official Journal of the International Mammalian Genome Society·D S GallagherJ E Womack
Apr 1, 1998·Clinical and Diagnostic Laboratory Immunology·G HetlandM Harboe
Sep 25, 1998·The Journal of General Virology·P C ReadingE M Anders
Aug 3, 2001·Nature Reviews. Molecular Cell Biology·D G Russell
Nov 14, 2001·Infection and Immunity·S L Mueller-OrtizS J Norris
Jan 22, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·J Scott FergusonLarry S Schlesinger
Sep 12, 2002·Biochimica Et Biophysica Acta·Jinhua LuKenneth B M Reid
May 17, 2003·The Journal of Clinical Investigation·Huixing WuFrancis X McCormack
Oct 11, 2005·Molecular Immunology·Uday KishoreTrinad Chakraborty
Nov 4, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Carl G FengAlan Sher
Aug 19, 2008·Trends in Microbiology·Piran C L WhiteMichael R Hutchings
Aug 25, 2009·Molecular Immunology·Maria V CarrollRobert B Sim
Mar 5, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Katrin D Mayer-BarberAlan Sher
Jan 8, 2013·The Veterinary Record·D A AbernethyS J More
Jun 25, 2015·Microbiology Spectrum·Monika JankuteGurdyal S Besra
Sep 21, 2018·Frontiers in Immunology·Cristina CasalsDolores Solís

❮ Previous
Next ❯

Citations

Jan 28, 2021·Medicina·Heena Jagatia, Anthony G Tsolaki
Dec 7, 2021·Frontiers in Veterinary Science·Jorge Luis Mazorra-CarrilloHugo Esquivel-Solís

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
Assay
Fluorescence Microscopy
nuclear translocation

Software Mentioned

Image J
StepOne
GraphPad
GraphPad Prism

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.